India’s first indigenous bird flu vaccine developed in Bhopal:Single dose protects chickens for 6 months; launch scheduled for Nov 20
Scientists in Bhopal have developed India’s first indigenous vaccine to protect poultry farms and the poultry industry against the highly dangerous H5N1 bird flu virus. The National Institute of High Security Animal Diseases (ICAR-NIHSAD), under the Indian Council of Agricultural Research (ICAR), has developed the vaccine against virus clade 2.3.2.1a. A single dose is expected to provide protection to chickens for six months. Union Agriculture Minister Shivraj Singh Chouhan will launch the vaccine at the institute’s campus in Bhopal on November 20. Inactivated vaccine to protect layer and breeder chickens The vaccine is inactivated, and trials have shown encouraging results in laying hens and breeder chickens. It will primarily be used to vaccinate layer and breeder birds at poultry farms. Until now, India did not have an indigenous vaccine approved for commercial use against this particular strain of the virus. Bird flu outbreaks can cause mass culling and heavy financial losses The H5N1 virus is highly lethal to chickens and can kill almost the entire poultry population at an infected farm. When an outbreak occurs, large numbers of birds in the affected area have to be culled to contain the spread of the infection. This results in substantial financial losses for poultry businesses and farmers. India reported its first bird flu outbreak in 2006. Since then, more than 500 cases have been reported across the country. The poultry industry was estimated to have suffered losses of around ₹2,200 crore to ₹3,000 crore during the initial outbreak itself. Layer and breeder chickens stand to benefit the most The vaccine is expected to benefit layer and breeder chickens the most. Layers are reared for egg production, while breeder birds are kept for reproduction. Both have a longer lifespan than broiler chickens, making long-term protection against infection important. A single dose providing protection for six months could also reduce the need for repeated vaccinations. Preventing infection in poultry could lower human exposure risk The H5N1 virus can also infect humans, with contact with infected birds posing a risk of transmission. In humans, the infection can cause high fever, breathing difficulties and severe pneumonia. According to World Health Organization data, 1,003 human cases of H5N1 infection have been reported worldwide since 2003, resulting in 479 deaths. Preventing infections in poultry could help reduce the risk of transmission to humans. However, regular monitoring, farm biosecurity measures and avoiding contact with infected birds will remain essential. Foreign vaccines were not designed for India’s virus strain Countries such as China, Egypt and Vietnam have also developed bird flu vaccines. However, these vaccines were developed to target different clades of the virus found in those countries. In India, H5N1 clade 2.3.2.1a has posed a serious challenge to poultry. Scientists in Bhopal have therefore developed an indigenous vaccine specifically targeting this strain. Vaccination to be carried out under veterinary supervision The vaccine will be introduced at commercial poultry farms in phases. Chickens will be administered the dose under the supervision of veterinarians and trained staff, following established protocols. The aim is to prevent bird flu outbreaks and minimise the economic losses suffered by the poultry industry.
Search
Recent
- Panel to address issues related to MRPL blast: Khader
- Himachal BJP to hold protest over pending women’s aid
- After 3 years of woes: Mohali’s sewage treatment plant to start operations today
- 2 bike-borne men open fire at SUV in Zirakpur
- Mohali: Murder charges invoked after toddler found dead on neighbour’s terrace